Literature DB >> 16930776

Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration.

Keith A Josephs1, Dennis W Dickson.   

Abstract

Tau-negative frontotemporal lobar degeneration (FTLD) can be divided into those with motor neuron disease (FTLD-MND), and those without MND, but with ubiquitin-immunoreactive neuronal inclusions (FTLD-U). Some authors group FTLD-U and FTLD-MND together as tau-negative FTLD, but others separate them on the basis of clinical, pathologic and imaging differences. In 103 cases of pathologically confirmed, tau-negative FTLD (FTLD-MND and FTLD-U), we assessed the frequency of hippocampal sclerosis defined as neuronal loss in the subicular or CA1 regions of the hippocampus. The subjects in the FTLD-U group were older at death and had longer disease duration. After adjusting for age at death and disease duration, we found a significant difference in the frequency of hippocampal sclerosis in the FTLD-U group (79%) compared to FTLD-MND group (26%) (p=0.02). The difference in frequency of HpScl in FTLD-U compared to FTLD-MND is further evidence that they are separate clinicopathologic entities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930776     DOI: 10.1016/j.neurobiolaging.2006.07.010

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  26 in total

Review 1.  Visual spatial cognition in neurodegenerative disease.

Authors:  Katherine L Possin
Journal:  Neurocase       Date:  2010-06-02       Impact factor: 0.881

2.  FTLD-TDP With and Without GRN Mutations Cause Different Patterns of CA1 Pathology.

Authors:  Qinwen Mao; Xiaojing Zheng; Tamar Gefen; Emily Rogalski; Callen L Spencer; Rosa Rademakers; Angela J Fought; Missia Kohler; Sandra Weintraub; Haibin Xia; Marek-Marsel Mesulam; Eileen H Bigio
Journal:  J Neuropathol Exp Neurol       Date:  2019-09-01       Impact factor: 3.685

Review 3.  Making the diagnosis of frontotemporal lobar degeneration.

Authors:  Eileen H Bigio
Journal:  Arch Pathol Lab Med       Date:  2013-03       Impact factor: 5.534

4.  Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion.

Authors:  Olga Pletnikova; Kelly L Sloane; Alan E Renton; Bryan J Traynor; Barbara J Crain; Tammy Reid; Tao Zu; Laura P W Ranum; Juan C Troncoso; Peter V Rabins; Chiadi U Onyike
Journal:  Neurobiol Aging       Date:  2014-04-18       Impact factor: 4.673

5.  Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically.

Authors:  Winnie C Pao; Dennis W Dickson; Julia E Crook; NiCole A Finch; Rosa Rademakers; Neill R Graff-Radford
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Oct-Dec       Impact factor: 2.703

6.  Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders.

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2015-05-01       Impact factor: 3.575

7.  Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; Amanda M Serie; Ralph B Perkerson; Billie J Matchett; Clifford R Jack; David S Knopman; Ronald C Petersen; Joseph E Parisi; Leonard Petrucelli; Matthew Baker; Rosa Rademakers; Jennifer L Whitwell; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2019-01-02       Impact factor: 17.088

Review 8.  Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-Related Tauopathy.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Continuum (Minneap Minn)       Date:  2019-02

9.  Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes.

Authors:  Keith A Josephs; Alex Stroh; Brittany Dugger; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2009-05-20       Impact factor: 17.088

10.  Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype.

Authors:  K A Josephs; J L Whitwell; D S Knopman; W T Hu; D A Stroh; M Baker; R Rademakers; B F Boeve; J E Parisi; G E Smith; R J Ivnik; R C Petersen; C R Jack; D W Dickson
Journal:  Neurology       Date:  2008-04-09       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.